Clinical trial
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment: A Pilot Feasibility and Efficacy Study
NCT03207399 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment: A Pilot Feasibility and Efficacy Study
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 15, 2017
- Completion date
- March 25, 2019
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c, chronic, lung transplant